【摘要】 目的探讨人免疫球蛋白辅助治疗小儿重症肺炎的临床效果。方法该文研究整群选取研究对象118例,均为2012年4月—2015年6月该院收治的重症肺炎患儿,根据患儿在治疗期间接受的不同治疗措施将所有患儿分为两组,一组患儿为对照组,采用常规治疗联合丹参酮磺酸钠治疗,另一组患儿为观察组,在对照组治疗基础上加用人免疫球蛋白辅助治疗,分析两组治疗方案的有效性。结果观察组重症肺炎患儿体温恢复正常天数(3.13±1.43)d、炎症消失天数(8.41±1.23)d、咳嗽消失天数(4.32±1.33)d、啰音消失天数(6.44±1.65)d及住院天数(10.48±1.54)d明显优于对照组患儿,两组数据对比差异有统计学意义(P<0.05)。结论人免疫球蛋白辅助治疗小儿重症肺炎具有显著的临床效果,可有效缩短患儿症状缓解时间及住院时间,值得推广及采纳。更多还原

【Abstract】 Objective To discuss the clinical effect of adjunctive treatment of human immune globulin for severe pneumonia in children. Methods 118 cases of children with severe pneumonia admitted and treated in our hospital from April 2012 to June 2015 were selected as the research objects and divided into two groups according to the different treatment measures during the treatment period, the control group were treated with conventional method combined with salvianolic sodium, the observation group adopted adjunctive treatment of human immune globulin on the basis of the control group, and the effectiveness of the two treatment plans was analyzed. Results The days of body temperature normalization, disappearance time of inflammation, cough and rale and length of stay in the observation group were respectively(3.13 ±1.43) d,(8.41±1.23) d,(4.32±1.33) d,(6.44±1.65) d and(10.48±1.54) d, which were obviously better than those in the control group, and the differences in data between the two groups were obvious by comparison, P<0.05. Conclusion Adjunctive treatment of human immune globulin for severe pneumonia in children has an obvious clinical effect and it can effectively shorten symptom relief time and length of stay of children, which is worth promotion and adopting.更多还原